Goldman Sachs & United States — Food and Drug Administration
8 shared events · Importance 4 · Last updated Jun 08, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Business
Goldman Sachs: Goldman Sachs is hosting the Global Healthcare Conference, providing a platform for Oculis to present its updates.
United States — Food and Drug Administration: The United States — Food and Drug Administration granted Breakthrough Therapy designation to Oculis's Privosegtor, highlighting its potential.
Jun 08, 2026 · 6 articles
Business
Goldman Sachs: Goldman Sachs is hosting the 47th Annual Global Healthcare Conference 2026, providing a platform for companies like Coya Therapeutics to engage with the investment community.
United States — Food and Drug Administration: The United States — Food and Drug Administration is mentioned as the regulatory body whose approval is sought for Coya Therapeutics' therapies, highlighting the importance of regulatory milestones for the company's future.
Jun 02, 2026 · 7 articles
Business
Goldman Sachs: Goldman Sachs is hosting the 47th Annual Global Healthcare Conference, where Innoviva will participate in a fireside chat.
United States — Food and Drug Administration: The United States — Food and Drug Administration approved NUZOLVENCE, one of Innoviva's products.
Jun 01, 2026 · 6 articles
Business
Goldman Sachs: Goldman Sachs is hosting one of the investment bank conferences where AnBogen Therapeutics will present.
United States — Food and Drug Administration: The United States — Food and Drug Administration is currently reviewing the New Drug Application for rusfertide.
May 28, 2026 · 6 articles
NEWSDESK
Explore this relationship live
Track how Goldman Sachs and United States — Food and Drug Administration interact across events, view sentiment trends, and discover connected entities.
Open Dashboard